Invitris raises €450K Pre-Seed round
5 April 2023· Munich, Germany· health, biotech, synthetic_biology, b2b, software_hardware, drug_discovery
The funding is aimed at advancing Invitris's innovative biotech platform, Phactory, to accelerate the development of groundbreaking protein-based therapeutics, particularly the next generation of antibiotics. It will also be used for talent acquisition, technology enhancement, and expanding collaborations.
Investors
LeadY Combinator
About Invitris
Stage
Bridge
Headquarters
Munich, Germany
Founded
2018
Team Size
6–20
Sectors
healthbiotechsynthetic_biologyb2bsoftware_hardwaredrug_discovery